demonstrated that FOXP3+CD39+ Tregs (Figure 3) could suppress the production of IL‐17 by Th17 cells, while FOXP3+CD39− Tregs could produce IL‐17 in MS patients.256. The gene discussed is FOXP3; the disease is myeloid sarcoma.